Stereo Labs Private Limited
About Stereo Labs Private Limited
Data last updated:
Stereo Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2019PTC130220. Its GSTIN is 36ABBCS5288D1Z8 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nandini Vemula and Venkata Narayana Vemula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 5 – 5 – 35/207/C Plot No 12 Sakthipuram Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.46 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹1,495 (net margin 0%) and EBITDA of -₹1,495 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 58% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Stereo Labs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH No 5 – 5 – 35/207/C Plot No 12 Sakthipuram Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stereo Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stereo Labs is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Stereo Labs Private Limited, buy the company report.
Financials of Stereo Labs Private Limited
FY 2025 filings availableStereo Labs Private Limited reported revenue of ₹67.46 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 58% over five years, including 4% growth in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,495 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,495 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stereo Labs Private Limited, buy the company report.
Board of directors of Stereo Labs Private Limited
Stereo Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandini Vemula | Director | 09 Jan 2024 | 2 Years 9 Months | Current |
| Venkata Narayana Vemula Also directs: Any Pep Pharma Private Limited, Chemieblocks India Private Limited, Venkatasai Lifesciences Private Limited and 1 more | Director | 01 Feb 2019 | 7 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Stereo Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stereo Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stereo Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABBCS5288D1Z8 | Telangana | Active | 29 Apr 2019 |
To see the full GST registrations and return filing status of Stereo Labs Private Limited, buy the company report.
Recent activity
Stereo Labs Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Nandini Vemula was appointed as Director on 09 Jan 2024.
Frequently asked questions
Stereo Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 February 2019 (7+ years old) and is registered under CIN U24100TG2019PTC130220.
Stereo Labs has 2 current directors:
- Nandini Vemula - Director
- Venkata Narayana Vemula - Director
The latest financial statements of Stereo Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Stereo Labs is 36ABBCS5288D1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Stereo Labs is U24100TG2019PTC130220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stereo Labs was incorporated on 01 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nandini Vemula was appointed as Director on 09 Jan 2024. Ravikumar Chukka ceased to be Director on 09 Jan 2024. Venkata Narayana Vemula was appointed as Director on 01 Feb 2019.
The registered office of Stereo Labs is at H No 5 – 5 – 35207C Plot No 12 Sakthipuram Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Stereo Labs operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Stereo Labs is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.